Asthma Clinical Research Network (ACRN)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00000577
First received: October 27, 1999
Last updated: August 24, 2006
Last verified: August 2006
  Purpose

This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.


Condition Intervention Phase
Asthma
Lung Diseases
Drug: Albuterol
Drug: Colchicine
Drug: Adrenal Cortex Hormones
Drug: Adrenergic-Beta Agonists
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Asthma Clinical Research Network (ACRN)

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1993
Estimated Study Completion Date: July 2008
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Patients with asthma; specific eligibility criteria vary for each study.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000577

Locations
United States, California
University of California at San Diego
La Jolla, California, United States, 92103
University of California, San Francisco
San Francisco, California, United States, 94143
United States, Colorado
National Jewish Medical & Research Center
Denver, Colorado, United States, 80206
United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
United States, Missouri
Washington University
St. Louis, Missouri, United States, 63110
United States, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27103
United States, Wisconsin
University of Wisconsin at Madison
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
Investigators
Study Chair: Homer A. Boushey University of California, San Francisco
Study Chair: William Calhoun University of Pittsburgh at Pittsburgh
Study Chair: Mario Castro Washington University Early Recognition Center
Study Chair: Vernon Chinchilli Milton S. Hershey Medical Center
Study Chair: Elliot Israel Brigham and Women's Hospital
Study Chair: Robert F. Lemanske, Jr. University of Wisconsin, Madison
Study Chair: Richard J. Martin National Jewish Medical & Research Center
Study Chair: Stephen P. Peters Wake Forest School of Medicine
Study Chair: Stephen I. Wasserman University of California, San Diego
  More Information

Additional Information:
Publications:
King TS, Chinchilli VM and the Asthma Clinical Research Network:. Robust estimators of the concordance correlation coefficient. Joint Statistical Meetings, Page 50, August 2001.

ClinicalTrials.gov Identifier: NCT00000577     History of Changes
Other Study ID Numbers: 215, U10 HL51823, U10 HL51831, U10 HL51834, U10 HL51843, U10 HL51845, U10 HL56443, U10 HL74073, U10 HL74204, U10 HL74206, U10 HL74208, U10 HL74212, U10 HL74218, U10 HL74225, U10 HL74227, U10 HL74231, Y02 HL51810
Study First Received: October 27, 1999
Last Updated: August 24, 2006
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Asthma
Lung Diseases
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Adrenergic Agents
Albuterol
Adrenergic beta-Agonists
Colchicine
Hormones
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Adrenergic Agonists
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Therapeutic Uses
Tocolytic Agents
Reproductive Control Agents
Adrenergic beta-2 Receptor Agonists
Gout Suppressants
Antirheumatic Agents

ClinicalTrials.gov processed this record on August 20, 2014